FDA issued a Warning Letter to Cadila Healthcare Limited on 6/21/2011 as a result of this inspection.
FDA investigators audited the Cadila Healthcare - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 03 Feb 2011.
Product details
- Category: Human Drugs
- Inspection end: 03 Feb 2011
- Location: Ahmedabad, India
- FEI: 3002984011
